(Q38178788)

30 August 2017

title

Pulmonary drug delivery: from generating aerosols to overcoming biological barriers-therapeutic possibilities and technological challenges (English)

1 reference

30 August 2017

1 reference

3

Claus-Michael Lehr

1 reference

30 August 2017

Christian A Ruge

1

1 reference

30 August 2017

Julian Kirch

series ordinal

2

1 reference

30 August 2017

publication date

4 June 2013

1 reference

The Lancet. Respiratory medicine

30 August 2017

published in

1 reference

30 August 2017

volume

1

1 reference

30 August 2017

issue

5

1 reference

30 August 2017

page(s)

402-413

1 reference

The particle has landed--characterizing the fate of inhaled pharmaceuticals

30 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2813%2970072-9

7 January 2021

Pulmonary drug delivery. Part I: Physiological factors affecting therapeutic effectiveness of aerosolized medications

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2813%2970072-9

7 January 2021

The lungs as a portal of entry for systemic drug delivery

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2813%2970072-9

7 January 2021

Inhaling medicines: delivering drugs to the body through the lungs

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2813%2970072-9

7 January 2021

Deposition of inhaled particles in the human respiratory tract and consequences for regional targeting in respiratory drug delivery

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2813%2970072-9

7 January 2021

A theoretical approach to the deposition and clearance of fibers with variable size in the human respiratory tract

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2813%2970072-9

7 January 2021

Absorption of nicotine from small cigars

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2813%2970072-9

7 January 2021

Pulmonary delivery of therapeutic compounds for treating CNS disorders.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2813%2970072-9

7 January 2021

New ways of insulin delivery

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2813%2970072-9

7 January 2021

Nebulized anticoagulants for acute lung injury - a systematic review of preclinical and clinical investigations

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2813%2970072-9

7 January 2021

Challenges in inhaled product development and opportunities for open innovation

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2813%2970072-9

7 January 2021

Drug solubilization in lung surfactant

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2813%2970072-9

7 January 2021

Mucociliary clearance--a critical upper airway host defense mechanism and methods of assessment.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2813%2970072-9

7 January 2021

From mucins to mucus: toward a more coherent understanding of this essential barrier

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2813%2970072-9

7 January 2021

Mucins, mucus, and sputum

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2813%2970072-9

7 January 2021

Extracellular barriers in respiratory gene therapy.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2813%2970072-9

7 January 2021

Epithelium, cilia, and mucus: their importance in chronic rhinosinusitis

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2813%2970072-9

7 January 2021

Modelling mucociliary clearance.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2813%2970072-9

7 January 2021

Functional imaging of mucociliary phenomena: high-speed digital reflection contrast microscopy.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2813%2970072-9

7 January 2021

Deposition and biokinetics of inhaled nanoparticles

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2813%2970072-9

7 January 2021

Assessment of particle retention and clearance in the intrapulmonary conducting airways of hamster lungs with the fractionator.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2813%2970072-9

7 January 2021

Effective mucus clearance is essential for respiratory health

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2813%2970072-9

7 January 2021

Update on macrophage clearance of inhaled micro- and nanoparticles

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2813%2970072-9

7 January 2021

Alveolar lining layer is thin and continuous: low-temperature scanning electron microscopy of rat lung

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2813%2970072-9

7 January 2021

Structure of pulmonary surfactant membranes and films: the role of proteins and lipid-protein interactions.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2813%2970072-9

7 January 2021

Surfactant displaces particles toward the epithelium in airways and alveoli

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2813%2970072-9

7 January 2021

Nanoparticle interaction with model lung surfactant monolayers.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2813%2970072-9

7 January 2021

Pulmonary surfactant: an immunological perspective

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2813%2970072-9

7 January 2021

Uptake of nanoparticles by alveolar macrophages is triggered by surfactant protein A.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2813%2970072-9

7 January 2021

The interplay of lung surfactant proteins and lipids assimilates the macrophage clearance of nanoparticles

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2813%2970072-9

7 January 2021

Global cancer statistics

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2813%2970072-9

7 January 2021

Formulations for pulmonary administration of anticancer agents to treat lung malignancies

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2813%2970072-9

7 January 2021

Inhaled chemotherapy in lung cancer: future concept of nanomedicine

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2813%2970072-9

7 January 2021

Inhaled drug therapy for treatment of tuberculosis

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2813%2970072-9

7 January 2021

Aerosol drug delivery: developments in device design and clinical use.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2813%2970072-9

7 January 2021

Pulmonary drug delivery. Part II: The role of inhalant delivery devices and drug formulations in therapeutic effectiveness of aerosolized medications

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2813%2970072-9

7 January 2021

Formulation strategy and use of excipients in pulmonary drug delivery

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2813%2970072-9

7 January 2021

PRINT: a novel platform toward shape and size specific nanoparticle theranostics

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2813%2970072-9

7 January 2021

Microfabricated engineered particle systems for respiratory drug delivery and other pharmaceutical applications.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2813%2970072-9

7 January 2021

Template-Assisted Polyelectrolyte Encapsulation of Nanoparticles into Dispersible, Hierarchically Nanostructured Microfibers

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2813%2970072-9

7 January 2021

Novel approaches for drug delivery systems in nanomedicine: effects of particle design and shape.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2813%2970072-9

7 January 2021

Controlled pulmonary drug and gene delivery using polymeric nano-carriers

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2813%2970072-9

7 January 2021

Fluticasone and budesonide nanosuspensions for pulmonary delivery: preparation, characterization, and pharmacokinetic studies

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2813%2970072-9

7 January 2021

Advances in the pulmonary delivery of poorly water-soluble drugs: influence of solubilization on pharmacokinetic properties

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2813%2970072-9

7 January 2021

Trojan particles: large porous carriers of nanoparticles for drug delivery.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2813%2970072-9

7 January 2021

Developing an efficient and reliable dry powder inhaler for pulmonary drug delivery--a review for multidisciplinary researchers

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2813%2970072-9

7 January 2021

Nanoparticle formulations in pulmonary drug delivery

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2813%2970072-9

7 January 2021

Respirable microspheres for inhalation: the potential of manipulating pulmonary disposition for improved therapeutic efficacy

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2813%2970072-9

7 January 2021

Nanoparticles of glycol chitosan and its thiolated derivative significantly improved the pulmonary delivery of calcitonin.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2813%2970072-9

7 January 2021

Mucoadhesive nanoparticulate systems for peptide drug delivery

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2813%2970072-9

7 January 2021

Addressing the PEG mucoadhesivity paradox to engineer nanoparticles that "slip" through the human mucus barrier

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2813%2970072-9

7 January 2021

Mucoadhesive polymeric platforms for controlled drug delivery

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2813%2970072-9

7 January 2021

Oral drug absorption enhancement by chitosan and its derivatives

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2813%2970072-9

7 January 2021

Thiomers: a new generation of mucoadhesive polymers

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2813%2970072-9

7 January 2021

Oral delivery of therapeutic protein/peptide for diabetes--future perspectives.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2813%2970072-9

7 January 2021

Improving oral absorption via drug-loaded nanocarriers: absorption mechanisms, intestinal models and rational fabrication

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2813%2970072-9

7 January 2021

Rapid transport of large polymeric nanoparticles in fresh undiluted human mucus

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2813%2970072-9

7 January 2021

Mucociliary clearance of micro- and nanoparticles is independent of size, shape and charge--an ex vivo and in silico approach.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2813%2970072-9

7 January 2021

Optical tweezers reveal relationship between microstructure and nanoparticle penetration of pulmonary mucus

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2813%2970072-9

7 January 2021

Characterization of superparamagnetic nanoparticle interactions with extracellular matrix in an in vitro system.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2813%2970072-9

7 January 2021

Recent advances in pulmonary drug delivery using large, porous inhaled particles

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2813%2970072-9

7 January 2021

Swellable microparticles as carriers for sustained pulmonary drug delivery

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2813%2970072-9

7 January 2021

Shape induced inhibition of phagocytosis of polymer particles

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2813%2970072-9

7 January 2021

Effect of PEGylation on the stability of liposomes during nebulisation and in lung surfactant.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2813%2970072-9

7 January 2021

Influence of particle size on regional lung deposition--what evidence is there?

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2813%2970072-9

7 January 2021

Targeted drug-aerosol delivery in the human respiratory system

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2813%2970072-9

7 January 2021

Targeted delivery of magnetic aerosol droplets to the lung

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2813%2970072-9

7 January 2021

EGF receptor-targeted nanocarriers for enhanced cancer treatment

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2813%2970072-9

7 January 2021

Targeting strategies for multifunctional nanoparticles in cancer imaging and therapy

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2813%2970072-9

7 January 2021

Targeted delivery of transferrin-conjugated liposomes to an orthotopic model of lung cancer in nude rats

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2813%2970072-9

7 January 2021

In vitro assessment of transferrin-conjugated liposomes as drug delivery systems for inhalation therapy of lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2813%2970072-9

7 January 2021

Nanobead-based interventions for the treatment and prevention of tuberculosis

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2813%2970072-9

7 January 2021

Cellular targeting and trafficking of drug delivery systems for the prevention and treatment of MTb.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2813%2970072-9

7 January 2021

The development of gene therapy for diseases of the lung

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2813%2970072-9

7 January 2021

Targeted gene delivery to the lung

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2813%2970072-9

7 January 2021

Liposomal delivery of proteins and peptides

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2813%2970072-9

7 January 2021

The influence of chitosan content in cationic chitosan/PLGA nanoparticles on the delivery efficiency of antisense 2'-O-methyl-RNA directed against telomerase in lung cancer cells

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2813%2970072-9

7 January 2021

Pulmonary formulations: what remains to be done?

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2813%2970072-9

7 January 2021

10.1016/S2213-2600(13)70072-9

Identifiers

DOI

1 reference

30 August 2017

1 reference